Cargando…
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience
Dosing regimens for antithymocyte globulin (ATG) and anti-CD52 antibody (alemtuzumab) for graft vs. host disease prophylaxis (GVHD) are empiric or weight-based, and do not account for individual patient factors. Recently, it has been shown that recipient peripheral blood absolute lymphocyte count (A...
Autores principales: | Sheth, Vipul, Kennedy, Vanessa, de Lavallade, Hugues, Mclornan, Donal, Potter, Victoria, Engelhardt, Brian G., Savani, Bipin, Chinratanalab, Wichai, Goodman, Stacey, Greer, John, Kassim, Adetola, York, Sally, Kenyon, Michelle, Gandhi, Shreyans, Kulasekararaj, Austin, Marsh, Judith, Mufti, Ghulam, Pagliuca, Antonio, Jagasia, Madan, Raj, Kavita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636242/ https://www.ncbi.nlm.nih.gov/pubmed/31355140 http://dx.doi.org/10.3389/fonc.2019.00623 |
Ejemplares similares
-
Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study
por: Sheth, Vipul, et al.
Publicado: (2021) -
Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials
por: Sengsayadeth, Salyka, et al.
Publicado: (2013) -
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant
por: Patel, Dilan A., et al.
Publicado: (2021) -
New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
por: Mangan, Brendan L., et al.
Publicado: (2020) -
Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Eplin, Dwight D., et al.
Publicado: (2019)